Compare Kioson Komersial Indonesia Tbk (KIOS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kioson Komersial Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp92 (market cap 100.06B, 38.92M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kioson Komersial Indonesia Tbk is more actively traded (38.92M versus 96.7K). Which is the better fit depends on your goals.
| KIOS | OBAT | |
|---|---|---|
Market Cap | 100.06B | 167.37B |
Volume | 38.92M | 96.7K |
Lot | 389.22K | 967 |
Turnover | 3.62B | 23.82M |
Average Price | 93.12 | 246.34 |
Value | 3.62B | 23.82M |
Indicative Equilibrium Price | 92 | 248 |
Indicative Equilibrium Volume | 1.83K | 41 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kioson Komersial Indonesia Tbk
PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.
Read more on KIOS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
